Home › Core › ISCC-IDs › 28C5sraZsY943

View ISCC-ID

Core Data

28C5sraZsY943
ISCC-ID - digital asset identifier
CCMDJ3sYBaUdp-CTaNHyeyfgAEp-CDZ7iS4YTg41E-CR5U2zSqCEjwx
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

recent advances in understanding the antineoplastic mechanisms of farnesyltransferase inhibitors figure 1

Ledger Reference

coblo
Source Ledger/Blockchain
12406134
N-th ISCC Decleration on source ledger
398d1645f9cedbad4ad5ec3554e3300f6d798e2178eb1c8d0423af901a5472b5
Hash of block that includes the ISCC-DECLARATION
2e191b21f70ffc94c471482824636e7b3ccf5a4ba5b0978264daae6f9daa65bc
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Recent Advances in Understanding the Antineoplastic Mechanisms of Farnesyltransferase Inhibitors: Figure 1.", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Jingxuan Pan", "@type": "Person"}, {"name": "Sai-Ching Jim Yeung", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://cancerres.aacrjournals.org/content/65/20/9109.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Association for Cancer Research (AACR)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1158/0008-5472.can-05-2635", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCMDJ3sYBaUdp-CTaNHyeyfgAEp-CDZ7iS4YTg41E-CR5U2zSqCEjwx", "propertyID": "ISCC"}], "datePublished": "2005-10-15"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close